NCLT approves amalgamation of Lincoln Parenteral & Lincoln Pharmaceuticals
Amalgamation of Lincoln Parenteral and Lincoln Pharmaceuticals is expected to bring lots of synergies in terms of operations efficiency, enhance competitive strength, cost-effectiveness and productivity for the combined entity, Lincoln Pharmaceuticals said.
What has changed in the last 5 yrs while stock is consolidating?
Mgmt has successfully transformed a low-margin trading company into a medium complex drug formulation business. This can be seen in having flat revenue growth but as expected, the margins h......read more